Your browser doesn't support javascript.
In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.
Wratil, Paul R; Schmacke, Niklas A; Osterman, Andreas; Weinberger, Tobias; Rech, Jochen; Karakoc, Burak; Zeilberger, Mira; Steffen, Julius; Mueller, Tonina T; Spaeth, Patricia M; Stern, Marcel; Albanese, Manuel; Thun, Hella; Reinbold, Julia; Sandmeyer, Benedikt; Kressirer, Philipp; Grabein, Béatrice; Falkai, Peter; Adorjan, Kristina; Hornung, Veit; Kaderali, Lars; Klein, Matthias; Keppler, Oliver T.
  • Wratil PR; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany. wratil@mvp.lmu.de.
  • Schmacke NA; German Center for Infection Research (DZIF), Partner site, Munich, Germany. wratil@mvp.lmu.de.
  • Osterman A; Department of Biochemistry and Gene Center, LMU München, Munich, Germany.
  • Weinberger T; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
  • Rech J; Department of Medicine I, University Hospital, LMU München, Munich, Germany.
  • Karakoc B; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Zeilberger M; Department of Biochemistry and Gene Center, LMU München, Munich, Germany.
  • Steffen J; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
  • Mueller TT; Department of Medicine IV, University Hospital, LMU München, Munich, Germany.
  • Spaeth PM; Department of Medicine I, University Hospital, LMU München, Munich, Germany.
  • Stern M; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Albanese M; Department of Medicine I, University Hospital, LMU München, Munich, Germany.
  • Thun H; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
  • Reinbold J; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
  • Sandmeyer B; Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
  • Kressirer P; Department of Communication and Media, University Hospital, LMU München, Munich, Germany.
  • Grabein B; Department of Communication and Media, University Hospital, LMU München, Munich, Germany.
  • Falkai P; Institute of Emergency Medicine and Management in Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Adorjan K; Department of Communication and Media, University Hospital, LMU München, Munich, Germany.
  • Hornung V; Department for Clinical Microbiology and Hospital Hygiene, University Hospital, LMU München, Munich, Germany.
  • Kaderali L; Department of Psychiatry and Psychotherapy, University Hospital, LMU München, Munich, Germany.
  • Klein M; Department of Psychiatry and Psychotherapy, University Hospital, LMU München, Munich, Germany.
  • Keppler OT; Department of Biochemistry and Gene Center, LMU München, Munich, Germany.
Infection ; 50(2): 381-394, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1351389
ABSTRACT

PURPOSE:

To determine risk factors for coronavirus disease 2019 (COVID-19) in healthcare workers (HCWs), characterize symptoms, and evaluate preventive measures against SARS-CoV-2 spread in hospitals.

METHODS:

In a cross-sectional study conducted between May 27 and August 12, 2020, after the first wave of the COVID-19 pandemic, we obtained serological, epidemiological, occupational as well as COVID-19-related data at a quaternary care, multicenter hospital in Munich, Germany.

RESULTS:

7554 HCWs participated, 2.2% of whom tested positive for anti-SARS-CoV-2 antibodies. Multivariate analysis revealed increased COVID-19 risk for nurses (3.1% seropositivity, 95% CI 2.5-3.9%, p = 0.012), staff working on COVID-19 units (4.6% seropositivity, 95% CI 3.2-6.5%, p = 0.032), males (2.4% seropositivity, 95% CI 1.8-3.2%, p = 0.019), and HCWs reporting high-risk exposures to infected patients (5.5% seropositivity, 95% CI 4.0-7.5%, p = 0.0022) or outside of work (12.0% seropositivity, 95% CI 8.0-17.4%, p < 0.0001). Smoking was a protective factor (1.1% seropositivity, 95% CI 0.7-1.8% p = 0.00018) and the symptom taste disorder was strongly associated with COVID-19 (29.8% seropositivity, 95% CI 24.3-35.8%, p < 0.0001). An unbiased decision tree identified subgroups with different risk profiles. Working from home as a preventive measure did not protect against SARS-CoV-2 infection. A PCR-testing strategy focused on symptoms and high-risk exposures detected all larger COVID-19 outbreaks.

CONCLUSION:

Awareness of the identified COVID-19 risk factors and successful surveillance strategies are key to protecting HCWs against SARS-CoV-2, especially in settings with limited vaccination capacities or reduced vaccine efficacy.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Etiology study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Humans / Male Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-021-01672-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Etiology study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Humans / Male Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-021-01672-z